Label: FINAPLIX-H- trenbolone acetate implant

  • NDC Code(s): 57926-040-01
  • Packager: Merck Sharp & Dohme Corp.
  • Category: OTC ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated March 1, 2022

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    For Heifers
    Fed In Confinement
    For Slaughter

  • DESCRIPTION

    Finaplix®-H (trenbolone acetate) is an implant containing 200 mg of trenbolone. Each implant consists of 10 small yellow pellets. Ten implants are provided in a cartridge.

    Manufactured by a non-sterilizing process.

  • INDICATIONS FOR USE

    Increases rate of weight gain and improves feed efficiency in a slow-release delivery system. This product is to be used in feedlot heifers only during approximately the last 63 days prior to slaughter.

    Do not use in veal calves. Effectiveness and animal safety in veal calves have not been established.

  • DOSAGE & ADMINISTRATION

    DOSAGE

    One implant containing 200 mg trenbolone acetate is administered to each animal. The 10 pellets which make up the dosage of Finaplix®-H are contained in one division of the multiple dose cartridge. Ten doses are in each cartridge. The cartridge is designed to be used with a special implant gun.

  • DOSAGE & ADMINISTRATION

    ROUTE OF ADMINISTRATION

    The implant is placed under the skin on the posterior aspect of the ear by means of a special implanter available from Intervet Inc.

    With the animal suitably restrained, the skin on the outer surface of the ear should be cleaned. The implant is then administered by the method shown in the diagram below.

    Fig. 1
  • SPL UNCLASSIFIED SECTION

    SITE OF IMPLANTATION

    After appropriately restraining the animal to allow access to the ear, cleanse the skin at the implant needle puncture site. It is subcutaneous between the skin and cartilage on the back side of the ear and below the midline of the ear. The implant must not be placed closer to the head than the edge of the cartilage ring farthest from the head. The location of insertion of the needle is a point toward the tip of the ear and at least a needle length away from the intended deposition site. Care should be taken to avoid injuring the major blood vessels or cartilage of the ear.

    Fig. 2
  • SPL UNCLASSIFIED SECTION

    METHOD OF USE

    1. Do not remove the cap of the cartridge containing the implants.
    2. Place the cartridge (D) with the capped end to the front into slot at the top of the implanter magazine marked (A) on the diagram.
    3. Gently push the cartridge into the slot until it clicks into place.
    4. The implanter is then ready for use.
    5. Take the ear of the animal firmly with the free hand in the manner shown in Fig. 1. Then insert the needle into the subcutaneous tissue at the point indicated in Fig. 2.
    6. After inserting the needle to its full extent, squeeze the trigger (E) gradually. Allow the pellets of the implant to be deposited in a single row.
    7. Withdraw the implanter. This will advance the cartridge one groove in the magazine and the next implant is now ready for use.
    8. When all the implants have been administered, the cartridge will discharge out the bottom of the magazine and may be replaced by a new one.
    9. To change the needle, loosen the needle locking nut labeled (F) in Fig. 3 and replace the needle. Tighten the nut finger tight and the implanter is ready for use.
    Fig. 3
  • WARNINGS

    WARNING

    Not to be used in animals intended for subsequent breeding, or in dairy animals. For Animal Treatment Only. Not for Use in Humans. Implant pellets in the ear only. Any other location is in violation of Federal Law. Do not attempt salvage of implanted site for human or animal food.

    A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.

  • STORAGE AND HANDLING

    STORAGE CONDITIONS

    Store unopened product at or below 25°C (77°F). Avoid excessive heat and humidity. Use product before the expiration date printed on the label and on the cartridge pouch. Opened cartridges may be stored in the foil pouch protected from light in the refrigerator (2-8°C/36-47°F) for up to 6 months.

  • HOW SUPPLIED

    Box of 10 × 10 cartridge implants.

  • SPL UNCLASSIFIED SECTION

    Made in Austria by:
    Intervet GesmbH

    Distributed by:
    Intervet Inc (d/b/a Merck Animal Health)
    Madison, NJ 07940

    Restricted Drug (California) - Use only as Directed

    Rev. 03/15

    NADA # 138-612, Approved by FDA

    Finaplix is a registered trademark of Intervet Inc. or an affiliate.

    152443 R1

  • PRINCIPAL DISPLAY PANEL - 10 x 10 Cartridge Implant Box

    Finaplix®-H
    (trenbolone acetate)

    For Heifers
    Fed In Confinement
    For Slaughter

    Box of 10 x 10 Cartridge Implants

    Manufactured by a non-sterilizing process
    Restricted Drug (California) - Use only as directed.

    MERCK
    Animal Health

    PRINCIPAL DISPLAY PANEL - 10 x 10 Cartridge Implant Box
  • INGREDIENTS AND APPEARANCE
    FINAPLIX-H 
    trenbolone acetate implant
    Product Information
    Product TypeOTC ANIMAL DRUGItem Code (Source)NDC:57926-040
    Route of AdministrationSUBCUTANEOUS
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    trenbolone acetate (UNII: RUD5Y4SV0S) (trenbolone - UNII:P53R4420TR) trenbolone acetate200 mg
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:57926-040-0110 in 1 BOX
    110 in 1 CARTRIDGE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    NADANADA13861206/12/1987
    Labeler - Merck Sharp & Dohme Corp. (001317601)